Source:http://linkedlifedata.com/resource/pubmed/id/17806115
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-4-28
|
pubmed:abstractText |
We produced a chitosan/fucoidan micro complex-hydrogel as a carrier for controlled release of heparin binding growth factors such as fibroblast growth factor (FGF)-2. Material consisting of a soluble chitosan (CH-LA) mixed with fucoidan yielded a water-insoluble and injectable hydrogel with filamentous particles. In this study, we examined the ability of the chitosan/fucoidan complex-hydrogel to immobilize FGF-2 and to protect its activity, as well as the controlled release of FGF-2 molecules. The chitosan/fucoidan complex-hydrogel has high affinity for FGF-2 (K(d) = 5.4 x 10(-) (9)M). The interaction of FGF-2 with chitosan/fucoidan complex-hydrogel substantially prolonged the biological half-life time of FGF-2. It also protected FGF-2 from inactivation, for example by heat and proteolysis, and enhance FGF-2 activity. When FGF-2-containing complex-hydrogel was subcutaneously injected into the back of mice, significant neovascularization and fibrous tissue formation were induced near the site of injection at 1 week, and the complex-hydrogel was biodegraded and disappeared by 4 weeks. These findings indicate that controlled release of biologically active FGF-2 molecules is caused by both slow diffusion and biodegradation of the complex-hydrogel, and that subsequent induction of vascularization occurs. FGF-2-containing chitosan/fucoidan micro complex-hydrogel is thus useful and convenient for treatment of ischemic disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chitosan,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogel,
http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/fucoidan
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1552-4965
|
pubmed:author |
pubmed-author:AmanoYoshikoY,
pubmed-author:AokiHiroshiH,
pubmed-author:HattoriHidemiH,
pubmed-author:IshiharaMasayukiM,
pubmed-author:IshizukaTakamitsuT,
pubmed-author:KanataniYasuhiroY,
pubmed-author:KishimotoSatokoS,
pubmed-author:KiyosawaTomoharuT,
pubmed-author:MaeharaTadaakiT,
pubmed-author:NakamuraShingoS,
pubmed-author:NambuMasakiM,
pubmed-author:TakaseBonpeiB
|
pubmed:copyrightInfo |
Copyright 2007 Wiley Periodicals, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
619-27
|
pubmed:meshHeading |
pubmed-meshheading:17806115-Animals,
pubmed-meshheading:17806115-Chitosan,
pubmed-meshheading:17806115-Delayed-Action Preparations,
pubmed-meshheading:17806115-Drug Carriers,
pubmed-meshheading:17806115-Fibroblast Growth Factor 2,
pubmed-meshheading:17806115-Half-Life,
pubmed-meshheading:17806115-Hydrogel,
pubmed-meshheading:17806115-Ischemia,
pubmed-meshheading:17806115-Mice,
pubmed-meshheading:17806115-Neovascularization, Physiologic,
pubmed-meshheading:17806115-Polysaccharides
|
pubmed:year |
2008
|
pubmed:articleTitle |
Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
|
pubmed:affiliation |
Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.
|
pubmed:publicationType |
Journal Article
|